OCS: Oculis Holding AG Ordinary shares Company Profile & Statistics

About

Oculis Holding AG is a biopharmaceutical company which develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidate includes OCS-01, OCS-02 and OCS-05. Oculis Holding AG is based in Zug, Switzerland.

Info & Links

CEO

Eduardo Bravo Fernandez de Araoz

Headquarters

BAHNHOFSTRASSE 7
ZUG, V8 6300, SWITZERLAND

Auditor

Marcum LLP

Share holders

Employees

Oculis Holding AG Ordinary shares Statistics

Valuation Measures

Market Capitalization²

790.99M

Enterprise Value

751.25M

Enterprise Value/EBITDA(ttm)

-11.92

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

906.66

Price to Book(mrq)

7.84

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

-8043.28%

Profit Margin(ttm)

-6275.51%

Return on Equity(ttm)

-71.31%

Return on Invested Capital(ttm)

-59.56%

Return on Assets(ttm)

-56.85%

Income Statement

Revenue(ttm)

774.30K

Revenue Per Share(ttm)

Gross Profit(ttm)

774.30K

EBITDA(ttm)³

-63.01M

Net Income Available to Common(ttm)

-64.77M

Diluted EPS(ttm)

-1.93

Share Statistics

Beta (5Y Monthly)

-0.24

52-Week Change

58.21%

S&P 500 52-Week Change

7.67%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

0.00

% Held by Insiders

% Held by Institutions

22.30%

Balance Sheet

Total Cash(mrq)

91.37M

Total Cash Per Share(mrq)

Total Debt(mrq)

677.90K

Total Debt/Equity(mrq)

1.31%

Current Ratio(mrq)

4.02%

Quick Ratio(mrq)

4.02%

Book Value Per Share(mrq)

2.62

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.03

Free Cash Flow(ytd)

-43.12M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

OCS

Oculis Holding AG Ordinary shares

Oculis Holding AG Ordinary shares Profile